National Bank Financial Research Analysts Reduce Earnings Estimates for TSO3 Inc. (TSE:TOS)
TSO3 Inc. (TSE:TOS) – Analysts at National Bank Financial decreased their FY2017 EPS estimates for TSO3 in a research note issued on Wednesday. National Bank Financial analyst E. Leno now expects that the company will post earnings per share of ($0.08) for the year, down from their prior estimate of ($0.05).
Several other equities analysts have also recently weighed in on TOS. Royal Bank Of Canada reiterated an “outperform” rating and issued a C$4.25 price objective on shares of TSO3 in a research note on Wednesday, May 3rd. Canaccord Genuity reiterated a “buy” rating and issued a C$5.25 price objective on shares of TSO3 in a research note on Monday, June 26th. Finally, Scotiabank reiterated an “outperform” rating and issued a C$4.50 price objective on shares of TSO3 in a research note on Thursday, July 6th. Five equities research analysts have rated the stock with a buy rating, TSO3 presently has a consensus rating of “Buy” and a consensus target price of C$5.00.
COPYRIGHT VIOLATION WARNING: This piece of content was posted by American Banking News and is the sole property of of American Banking News. If you are reading this piece of content on another domain, it was copied illegally and reposted in violation of international copyright laws. The legal version of this piece of content can be accessed at https://www.americanbankingnews.com/2017/08/07/national-bank-financial-research-analysts-reduce-earnings-estimates-for-tso3-inc-tsetos.html.
In other news, Director Richard Mark Rumble sold 500,000 shares of the stock in a transaction that occurred on Tuesday, May 23rd. The shares were sold at an average price of C$3.00, for a total value of C$1,500,000.00.
TSO3 Inc engages in the research, development, production, maintenance, sale, and licensing of sterilization processes, related consumable supplies, and accessories for heat and moisture sensitive medical devices. The companys principal product is the STERIZONE VP4 sterilizer, a dual sterilant, low temperature sterilization system that utilizes vaporized hydrogen peroxide and ozone that is marketed in Canada and the United States.
Receive News & Ratings for TSO3 Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TSO3 Inc. and related companies with MarketBeat.com's FREE daily email newsletter.